Afuco™ Anti-Human PDGFRB ADCC Therapeutic Antibody (IMC-2C5), ADCC Enhanced

Anti-PDGFRB ADCC Enhanced Antibody (IMC-2C5) is an ADCC enhanced antibody produced by our Afuco™ platform. IMC-2C5 binds to both human and mouse PDGFRβ. And it is involved in the treatment of a broad range of human cancers.
Supplier Creative Biolabs
Product # AFC-678CL
Pricing Inquiry
Host Human
Target PDGFRB
Species Reactivity Human
Type ADCC enhanced antibody
Applications Inhib, FuncS
Storage
  • Short Term Storage: 4°C
  • Long Term Storage: -20°C
Feedback